IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,317,000 | -71.9% | 137,500 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $4,692,000 | -82.4% | 190,300 | -81.4% | 0.00% | -82.6% |
| Q2 2021 | $26,656,000 | +1108.9% | 1,024,400 | +1369.8% | 0.02% | +1050.0% |
| Q1 2021 | $2,205,000 | -18.2% | 69,696 | +20.0% | 0.00% | 0.0% |
| Q4 2020 | $2,696,000 | +294.7% | 58,069 | +179.9% | 0.00% | – |
| Q3 2020 | $683,000 | -12.9% | 20,745 | -27.7% | 0.00% | -100.0% |
| Q2 2020 | $784,000 | -33.6% | 28,700 | -32.7% | 0.00% | 0.0% |
| Q4 2019 | $1,180,000 | – | 42,637 | +426270.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 10 | -94.3% | 0.00% | – |
| Q4 2018 | $2,000 | -97.4% | 174 | -97.5% | 0.00% | – |
| Q3 2018 | $77,000 | +2.7% | 6,885 | -26.8% | 0.00% | – |
| Q4 2017 | $75,000 | – | 9,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |